Alex Kadet's Linkedin Analytics

At Gero, we are at the forefront of biotechnology, dedicated to unraveling the complexities of aging and chronic diseases through human data and advanced physics-informed machine learning. Our approach has earned us collaborations with leading institutions like Harvard Medical School, NYU, and the Roswell Park Cancer Center, as well as a strategic partnership with Pfizer to develop treatments for fibrotic diseases. Our goal is to not only treat age-related diseases but also extend human healthspan and lifespan. As the Chief Business Officer at Gero, I lead strategic partnerships and collaborations with pharmaceutical and biotechnology companies, academic institutions, and non-profit organizations to advance our mission of targeting the root causes of age-related diseases. Leveraging our ML-enabled platform and drug discovery pipeline, we strive to develop novel therapeutics that address age-related diseases and slow the aging process itself. I am passionate about science and its potential to eliminate chronic diseases and enhance human health and well-being. Through our groundbreaking research and development efforts, we aim to transform the future of healthcare, offering hope for more effective and sustainable solutions for age-related conditions.